P29692 (EF1D_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 145.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Elongation factor 1-delta Short name=EF-1-delta Alternative name(s): Antigen NY-CO-4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 281 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Isoform 1: EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP, regenerating EF-1-alpha for another round of transfer of aminoacyl-tRNAs to the ribosome. Ref.27 Isoform 2: Regulates induction of heat-shock-responsive genes through association with heat shock transcription factors and direct DNA-binding at heat shock promoter elements (HSE). Ref.27 |
| Subunit structure | EF-1 is composed of 4 subunits: alpha, beta, delta isoform 1, and gamma. Isoform 2 interacts with HSF1 and NFE2L2. Ref.27 |
| Subcellular location | |
| Tissue specificity | Isoform 2 is specifically expressed in brain, cerebellum and testis. Ref.27 |
| Induction | By homocysteine (HC), may mediate accelerated synthesis of free thiol-containing proteins in response to HC-induced oxidative stress. Also induced following exposure to ionizing radiation. Ref.10 Ref.11 |
| Sequence similarities | Belongs to the EF-1-beta/EF-1-delta family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ARHGAP21 | Q5T5U3 | 2 | EBI-358607,EBI-1642518 | |
| ATG7 | O95352 | 2 | EBI-358607,EBI-987834 | |
| CAMSAP2 | Q08AD1 | 2 | EBI-358607,EBI-1051869 | |
| EEF1G | P26641 | 3 | EBI-358607,EBI-351467 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P29692-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P29692-2) Also known as: eEF1BdeltaL; The sequence of this isoform differs from the canonical sequence as follows: 1-1: M → MRSGKASCTL...VSSLRPNRKM | ||||||
| Note: Contains a phosphoserine at position 91. Contains a phosphoserine at position 94. | ||||||
| Isoform 3 (identifier: P29692-3) The sequence of this isoform differs from the canonical sequence as follows: 40-63: Missing. | ||||||
| Note: Contains a phosphoserine at position 40. | ||||||
| Isoform 4 (identifier: P29692-4) The sequence of this isoform differs from the canonical sequence as follows: 78-96: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.9 | ||||||
| Chain | 2 – 281 | 280 | Elongation factor 1-delta | PRO_0000155046 | |||||
Regions | |||||||||
| Region | 80 – 115 | 36 | Leucine-zipper | ||||||
| Region | 173 – 281 | 109 | Catalytic (GEF) | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.9 | ||||||
| Modified residue | 17 | 1 | N6-acetyllysine Ref.24 | ||||||
| Modified residue | 107 | 1 | N6-acetyllysine Ref.24 | ||||||
| Modified residue | 117 | 1 | N6-acetyllysine Ref.24 | ||||||
| Modified residue | 129 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 133 | 1 | Phosphoserine Ref.12 Ref.14 Ref.15 Ref.17 Ref.19 Ref.20 Ref.22 Ref.25 Ref.29 | ||||||
| Modified residue | 147 | 1 | Phosphothreonine Ref.12 Ref.19 Ref.23 | ||||||
| Modified residue | 162 | 1 | Phosphoserine; by CK2 Ref.12 Ref.13 Ref.14 Ref.16 Ref.18 Ref.19 Ref.21 Ref.22 Ref.23 Ref.25 Ref.28 Ref.29 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 | 1 | M → MRSGKASCTLETVWEDKHKY EEAERRFYEHEATQAAASAQ QLPAEGPAMNGPGQDDPEDA DEAEAPDGGSRRDPRKSQDS RKPLQKKRKRSPKSGLGPAD LALLGLSAERVWLDKSLFDQ AESSYRQKLADVAAQAAWPP ALAPWGLCTHGNQVACHHVT WGIWVNKSSFDQAERAFVEW SQALLLAPDGSRRQGTPNTG QQVAVPDLAHQPSPPVNGQP PLGSLQALVREVWLEKPRYD AAERGFYEALFDGHPPGKVR LQERAGLAEGARRGRRDRRG RNILGNKRAGLRRADGEAPS ALPYCYFLQKDAEAPWLSKP AYDSAECRHHAAEALRVAWC LEAASLSHRPGPRSGLSVSS LRPNRKM in isoform 2. | VSP_037884 | |||||
| Alternative sequence | 40 – 63 | 24 | Missing in isoform 3. | VSP_043812 | |||||
| Alternative sequence | 78 – 96 | 19 | Missing in isoform 4. | VSP_045960 | |||||
Experimental info | |||||||||
| Sequence conflict | 34 | 1 | A → R in CAA79716. Ref.1 | ||||||
| Sequence conflict | 44 | 1 | S → T in CAA79716. Ref.1 | ||||||
| Sequence conflict | 209 | 1 | T → A in BAG56855. Ref.4 | ||||||
| Isoform 2: | |||||||||
| Sequence conflict | 189 | 1 | D → E in AAP35906. Ref.3 | ||||||
| Sequence conflict | 189 | 1 | D → E in EAW82228. Ref.4 | ||||||
| Sequence conflict | 189 | 1 | D → E in AAH07847. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The human leucine zipper-containing guanine-nucleotide exchange protein elongation factor-1 delta." Sanders J.P., Raggiaschi R., Morales J., Moeller W. Biochim. Biophys. Acta 1174:87-90(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DOMAIN LEUCINE ZIPPER. Tissue: Skin fibroblast. |
| [2] | "Characterization of human colon cancer antigens recognized by autologous antibodies." Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E., Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J. Int. J. Cancer 76:652-658(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Colon carcinoma. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). |
| [5] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3). Tissue: Brain, Lung and Muscle. |
| [9] | Bienvenut W.V., Potts A., Barblan J., Quadroni M. Submitted (JUL-2004) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-10 (ISOFORM 1), ACETYLATION AT ALA-2, MASS SPECTROMETRY. Tissue: B-cell lymphoma. |
| [10] | "Elongation factor 1 delta is enhanced following exposure to ionizing radiation." Jung M., Kondratyev A.D., Dritschilo A. Cancer Res. 54:2541-2543(1994) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION BY IONIZING RADIATION. |
| [11] | "Induction of acute translational response genes by homocysteine. Elongation factors-1alpha, -beta, and -delta." Chacko G., Ling Q., Hajjar K.A. J. Biol. Chem. 273:19840-19846(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION BY HOMOCYSTEINE. |
| [12] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Phosphoproteomic analysis of the human pituitary." Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F. Pituitary 9:109-120(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, MASS SPECTROMETRY. Tissue: Pituitary. |
| [14] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, MASS SPECTROMETRY. Tissue: Prostate cancer. |
| [15] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction." Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R. Mol. Cell. Proteomics 6:1952-1967(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [17] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, MASS SPECTROMETRY. Tissue: T-cell. |
| [19] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91 AND SER-94 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 (ISOFORM 3), MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, MASS SPECTROMETRY. Tissue: Liver. |
| [22] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, MASS SPECTROMETRY. |
| [23] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-147 AND SER-162, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [24] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17; LYS-107 AND LYS-117, MASS SPECTROMETRY. |
| [25] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [26] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [27] | "Transformation of eEF1Bdelta into heat-shock response transcription factor by alternative splicing." Kaitsuka T., Tomizawa K., Matsushita M. EMBO Rep. 12:673-681(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION (ISOFORM 2), INTERACTION WITH HSF1 AND NFE2L2 (ISOFORM 2), TISSUE SPECIFICITY (ISOFORM 2), DNA-BINDING (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORM 2). |
| [28] | "Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of as a substrate for CK2." Gyenis L., Duncan J.S., Turowec J.P., Bretner M., Litchfield D.W. J. Proteome Res. 10:4887-4901(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-162 BY CK2. |
| [29] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Z21507 mRNA. Translation: CAA79716.1. BT007242 mRNA. Translation: AAP35906.1. AK293339 mRNA. Translation: BAG56855.1. AC067930 Genomic DNA. No translation available. CH471162 Genomic DNA. Translation: EAW82227.1. CH471162 Genomic DNA. Translation: EAW82228.1. CH471162 Genomic DNA. Translation: EAW82229.1. CH471162 Genomic DNA. Translation: EAW82230.1. CH471162 Genomic DNA. Translation: EAW82232.1. BC007847 mRNA. Translation: AAH07847.1. BC009907 mRNA. Translation: AAH09907.1. BC012819 mRNA. Translation: AAH12819.1. BC062535 mRNA. Translation: AAH62535.1. BC094806 mRNA. Translation: AAH94806.1. |
| IPI | IPI00023048. IPI00642971. IPI01013278. |
| PIR | S34626. |
| RefSeq | NP_001123525.2. NM_001130053.2. NP_001123527.1. NM_001130055.2. NP_001123528.1. NM_001130056.2. NP_001123529.1. NM_001130057.2. NP_001182132.1. NM_001195203.1. NP_001951.2. NM_001960.4. NP_115754.3. NM_032378.4. |
| UniGene | Hs.333388. Hs.686554. Hs.703306. |
3D structure databases | |
| ProteinModelPortal | P29692. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P29692. 55 interactions. |
| MINT | MINT-1139610. |
| STRING | 9606.ENSP00000391944. |
PTM databases | |
| PhosphoSite | P29692. |
Polymorphism databases | |
| DMDM | 20141357. |
2D gel databases | |
| OGP | P29692. |
Proteomic databases | |
| PaxDb | P29692. |
| PRIDE | P29692. |
Protocols and materials databases | |
| DNASU | 1936. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000317198; ENSP00000317399; ENSG00000104529. ENST00000395119; ENSP00000378551; ENSG00000104529. ENST00000419152; ENSP00000388261; ENSG00000104529. ENST00000423316; ENSP00000410059; ENSG00000104529. ENST00000442189; ENSP00000391944; ENSG00000104529. ENST00000524624; ENSP00000435697; ENSG00000104529. ENST00000526838; ENSP00000436507; ENSG00000104529. ENST00000528610; ENSP00000431763; ENSG00000104529. ENST00000529272; ENSP00000434872; ENSG00000104529. |
| GeneID | 1936. |
| KEGG | hsa:1936. |
| UCSC | uc003yyp.2. human. uc003yys.3. human. |
Organism-specific databases | |
| CTD | 1936. |
| GeneCards | GC08M144661. |
| H-InvDB | HIX0034587. |
| HGNC | HGNC:3211. EEF1D. |
| HPA | HPA045101. |
| MIM | 130592. gene. |
| neXtProt | NX_P29692. |
| PharmGKB | PA27647. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG2092. |
| HOGENOM | HOG000207272. |
| HOVERGEN | HBG000787. |
| InParanoid | P29692. |
| KO | K15410. |
| OrthoDB | EOG4CJVGT. |
Enzyme and pathway databases | |
| Reactome | REACT_17015. Metabolism of proteins. REACT_71. Gene Expression. |
Gene expression databases | |
| ArrayExpress | P29692. |
| Bgee | P29692. |
| CleanEx | HS_EEF1D. |
| Genevestigator | P29692. |
| GermOnline | ENSG00000104529. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.70.60. 1 hit. |
| InterPro | IPR018940. EF-1_beta_acid_region_euk. IPR014717. Transl_elong_EF1B/ribosomal_S6. IPR001326. Transl_elong_EF1B_B/D_CS. IPR014038. Transl_elong_fac_EF1B_bsu/dsu. [Graphical view] |
| Pfam | PF10587. EF-1_beta_acid. 1 hit. PF00736. EF1_GNE. 1 hit. [Graphical view] |
| SMART | SM00888. EF1_GNE. 1 hit. [Graphical view] |
| SUPFAM | SSF54984. Transl_elong_EF1B_B/D_G_exch. 1 hit. |
| PROSITE | PS00824. EF1BD_1. 1 hit. PS00825. EF1BD_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | EEF1D. human. |
| GenomeRNAi | 1936. |
| NextBio | 7841. |
| SOURCE | Search... |
Entry information
| Entry name | EF1D_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P29692 Secondary accession number(s): B4DDU4 Q96I38 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
